Table 2.
Prevalence of Pfdhfr triple mutation and MOI by age among pregnant women in the study area.
| Age group | Number examined (%) | Number positive (%) | 3D7 (%)* | FC27 (%)* | MOI* | Triple Pfdhfr mutation (%)* | |
|---|---|---|---|---|---|---|---|
| Mutant | Wild type | ||||||
| 15–20 | 30 (15.0) | 8 (13.4) | 6 | 8 | 2.1 | 4 (50.0) | 4 (50.0) |
| 21–25 | 60 (30.0) | 18 (30.0) | 14 | 16 | 1.8 | 10 (55.6) | 8 (44.4) |
| 26–30 | 73 (36.5) | 22 (36.6) | 13 | 20 | 1.6 | 17 (77.3) | 5 (22.7) |
| 31–35 | 26 (13.0) | 10 (16.6) | 6 | 8 | 1.8 | 5 (50.0) | 5 (50.0) |
| >36 | 11 (5.5) | 2 (3.4) | 1 | 1 | 1.0 | 2 (100.0) | 0(0) |
| Total | 200 | 60 (30.0) | |||||
*
The difference between groups was not statistically significant.